Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware. more
Time Frame | ELYM | Sector | S&P500 |
---|
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Profit | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 4.70M | 11.77M | 35.67M | 45.13M | 37.41M | [{"date":"2019-12-31","value":10.4,"profit":true},{"date":"2020-12-31","value":26.07,"profit":true},{"date":"2021-12-31","value":79.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.88,"profit":true}] |
Operating Income | (7.45M) | (20.93M) | (35.67M) | (45.13M) | (21.47M) | [{"date":"2019-12-31","value":-744600000,"profit":false},{"date":"2020-12-31","value":-2092500000,"profit":false},{"date":"2021-12-31","value":-3567200000,"profit":false},{"date":"2022-12-31","value":-4513500000,"profit":false},{"date":"2023-12-31","value":-2146600000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | 1.27M | (9.03M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-713.51,"profit":false}] |
Pre-Tax Income | (6.55M) | (20.67M) | (47.48M) | (45.24M) | (35.12M) | [{"date":"2019-12-31","value":-654700000,"profit":false},{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}] |
Income Taxes | (2.75M) | (9.16M) | (66.56K) | 109.00K | (21.47K) | [{"date":"2019-12-31","value":-2522.94,"profit":false},{"date":"2020-12-31","value":-8401.83,"profit":false},{"date":"2021-12-31","value":-61.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.69,"profit":false}] |
Income After Taxes | - | - | - | (45.35M) | (35.10M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-4535300000,"profit":false},{"date":"2023-12-31","value":-3509753400,"profit":false}] |
Income From Continuous Operations | (6.55M) | (20.67M) | (95.08M) | (45.24M) | (39.24M) | [{"date":"2019-12-31","value":-654700000,"profit":false},{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-9508300000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3924000000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (3.80M) | (11.51M) | (47.48M) | (45.35M) | (35.12M) | [{"date":"2019-12-31","value":-379700000,"profit":false},{"date":"2020-12-31","value":-1151000000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4535300000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}] |
EPS (Diluted) | - | - | (4.21) | (1.72) | (0.72) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-421,"profit":false},{"date":"2022-12-31","value":-172,"profit":false},{"date":"2023-12-31","value":-72.25,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ELYM | |
---|---|
Cash Ratio | 59.65 |
Current Ratio | 60.41 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ELYM | |
---|---|
ROA (LTM) | -24.54% |
ROE (LTM) | -38.35% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ELYM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.02 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.98 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ELYM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.97 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 0.58 |
Eliem Therapeutics Inc (ELYM) share price today is $
Yes, Indians can buy shares of Eliem Therapeutics Inc (ELYM) on Vested. To buy Eliem Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ELYM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Eliem Therapeutics Inc (ELYM) via the Vested app. You can start investing in Eliem Therapeutics Inc (ELYM) with a minimum investment of $1.
You can invest in shares of Eliem Therapeutics Inc (ELYM) via Vested in three simple steps:
The 52-week high price of Eliem Therapeutics Inc (ELYM) is $11.55. The 52-week low price of Eliem Therapeutics Inc (ELYM) is $2.52.
The price-to-earnings (P/E) ratio of Eliem Therapeutics Inc (ELYM) is
The price-to-book (P/B) ratio of Eliem Therapeutics Inc (ELYM) is 0.97
The dividend yield of Eliem Therapeutics Inc (ELYM) is 0.00%
The market capitalization of Eliem Therapeutics Inc (ELYM) is $342.68M
The stock symbol (or ticker) of Eliem Therapeutics Inc is ELYM